ACHFF
Price
$1.10
Change
-$0.12 (-9.84%)
Updated
Dec 18 closing price
APLIF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 11 closing price
61 days until earnings call
Ad is loading...

ACHFF vs APLIF

Header iconACHFF vs APLIF Comparison
Open Charts ACHFF vs APLIFBanner chart's image
Arch Biopartners
Price$1.10
Change-$0.12 (-9.84%)
Volume$48.15K
CapitalizationN/A
Appili Therapeutics
Price$0.03
Change-$0.00 (-0.00%)
Volume$171.8K
CapitalizationN/A
ACHFF vs APLIF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACHFF vs. APLIF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHFF is a Hold and APLIF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ACHFF: $1.22 vs. APLIF: $0.03)
Brand notoriety: ACHFF and APLIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHFF: 132% vs. APLIF: 139%
Market capitalization -- ACHFF: $77.14M vs. APLIF: $2.97M
ACHFF [@Biotechnology] is valued at $77.14M. APLIF’s [@Biotechnology] market capitalization is $2.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHFF’s FA Score shows that 0 FA rating(s) are green whileAPLIF’s FA Score has 1 green FA rating(s).

  • ACHFF’s FA Score: 0 green, 5 red.
  • APLIF’s FA Score: 1 green, 4 red.
According to our system of comparison, APLIF is a better buy in the long-term than ACHFF.

Price Growth

ACHFF (@Biotechnology) experienced а -9.62% price change this week, while APLIF (@Biotechnology) price change was -7.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

APLIF is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ACHFF($77.1M) has a higher market cap than APLIF($2.97M). ACHFF YTD gains are higher at: 9.279 vs. APLIF (-2.868).
ACHFFAPLIFACHFF / APLIF
Capitalization77.1M2.97M2,599%
EBITDAN/AN/A-
Gain YTD9.279-2.868-324%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ACHFF: Fundamental Ratings
ACHFF
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ACHFF and

Correlation & Price change

A.I.dvisor tells us that ACHFF and CCCC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHFF
1D Price
Change %
ACHFF100%
-5.89%
CCCC - ACHFF
24%
Poorly correlated
-6.03%
AVTX - ACHFF
23%
Poorly correlated
-0.42%
ACAD - ACHFF
23%
Poorly correlated
+0.40%
ALDX - ACHFF
23%
Poorly correlated
+5.34%
EDSA - ACHFF
22%
Poorly correlated
-1.58%
More

APLIF and

Correlation & Price change

A.I.dvisor tells us that APLIF and GENFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLIF and GENFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLIF
1D Price
Change %
APLIF100%
N/A
GENFF - APLIF
24%
Poorly correlated
N/A
ARTH - APLIF
11%
Poorly correlated
+16.67%
ARGNF - APLIF
10%
Poorly correlated
N/A
AAVXF - APLIF
7%
Poorly correlated
N/A
ACHFF - APLIF
7%
Poorly correlated
-5.89%
More